BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 10, 2020
View Archived Issues
Greenwich LifeSciences presents phase IIb data for cancer vaccine GP-2/GM-CSF
Read More
Oncolytic virus combines best of both immune worlds
Read More
Rule-based screening for degraders
Read More
Activity profiling and crystal structures to guide the design of SARS-CoV-2 PLpro inhibitors
Read More
RGFP-963 demonstrates promise in mouse models of ALS
Read More
Phase I and II clinical data reported for human IL-12 gene therapy Ad-RTS-hIL-12
Read More
HDAC6 inhibition as potential new therapeutic strategy for ALS
Read More
Prothena reports positive 9-month data from phase I study of PRX-004
Read More
Positive topline data presented from phase Ib study of EDP-1815 in atopic dermatitis
Read More
Bristol-Myers Squibb discovers Nuclear receptor ROR-gammaT agonists
Read More
New aryl hydrocarbon receptor antagonists disclosed by Antidote IP Holdings
Read More
Dana-Farber Cancer Institute patents focal adhesion kinase inhibitors
Read More
New Na(+)/H(+) exchanger 3 inhibitors identified at Lilly
Read More
DMC issues recommendation regarding global phase III study of PLX-PAD in CLI
Read More
Senju Pharmaceutical describes PAC1/VPAC1/VPAC2 receptor ligands
Read More
New preclinical data confirms efficacy of apelin agonists in ARDS
Read More
Dosing initiates in phase I study of ALT-801 for the treatment of NASH
Read More
Resolve presents positive phase IIa data for RSLV-132 in patients with SLE
Read More
Activity seen with ZEN-003694 plus talazoparib in metastatic triple-negative breast cancer
Read More
Phase III VIOLET studies of oteseconazole for recurrent VVC meet primary endpoint
Read More
SABCS2020: Verzenio continues to show benefit, but time may topple monarchE
Read More
First phase III induction study with upadacitinib in ulcerative colitis meets primary endpoint
Read More
Applied Therapeutics reports MRS data on reduction of galactitol levels with AT-007 for galactosemia
Read More
ObsEva reports further phase III data on use of linzagolix for bleeding due to uterine fibroids
Read More
Editas submits IND for EDIT-301 for sickle cell disease
Read More
Cytokinetics advances phase II trial of CK-3773274 for symptomatic obstructive HCM
Read More
Rocket reports preliminary phase I data on RP-A501 for Danon disease
Read More
Week 48 data reported from phase III PEGASUS trial of pegcetacoplan in PNH
Read More
